These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34416630)

  • 21. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
    Brenes O; Arce F; Gätjens-Boniche O; Díaz C
    Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of Chemotherapy on the Antioxidant Status of Human Skin.
    Lee BN; Jung S; Darvin ME; Eucker J; Kühnhardt D; Sehouli J; Chekerov R; Patzelt A; Fuss H; Yu RX; Lademann J
    Anticancer Res; 2016 Aug; 36(8):4089-93. PubMed ID: 27466518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A network meta-analysis for toxicity of eight chemotherapy regimens in the treatment of metastatic/advanced breast cancer.
    Zhang XH; Hao S; Gao B; Tian WG; Jiang Y; Zhang S; Guo LJ; Luo DL
    Oncotarget; 2016 Dec; 7(51):84533-84543. PubMed ID: 27811367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protracted drug infusions in cancer treatment: an appraisal of 5-fluorouracil, doxorubicin, and platinums.
    DelaFlor-Weiss E; Uziely B; Muggia FM
    Ann Oncol; 1993 Nov; 4(9):723-33. PubMed ID: 8280652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sensitivity of clonogenic cells of human ascitic ovarian cancer to antitumor agents].
    Potapov SL; Korman DB; Shamaev VI; Ershova RB; Makarov OV
    Eksp Onkol; 1987; 9(4):47-50. PubMed ID: 3678125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversibility of the effects of the chemotherapeutic regimen for non-Hodgkin lymphoma, cyclophosphamide, doxorubicin, vincristine, and prednisone, on the male rat reproductive system and progeny outcome.
    Delbès G; Vaisheva F; Luu T; Marcon L; Hales BF; Robaire B
    Reprod Toxicol; 2010 Jun; 29(3):332-8. PubMed ID: 20096776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase Ib, open-label study to assess the safety of continuous oral treatment with afatinib in combination with two chemotherapy regimens: cisplatin plus paclitaxel and cisplatin plus 5-fluorouracil, in patients with advanced solid tumors.
    Vermorken JB; Rottey S; Ehrnrooth E; Pelling K; Lahogue A; Wind S; Machiels JP
    Ann Oncol; 2013 May; 24(5):1392-400. PubMed ID: 23293114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistance to cytotoxic drugs in DNA mismatch repair-deficient cells.
    Aebi S; Fink D; Gordon R; Kim HK; Zheng H; Fink JL; Howell SB
    Clin Cancer Res; 1997 Oct; 3(10):1763-7. PubMed ID: 9815561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic interactions of breast cancer chemotherapeutics with human doxorubicin reductases.
    Hofman J; Skarka A; Havrankova J; Wsol V
    Biochem Pharmacol; 2015 Aug; 96(3):168-78. PubMed ID: 25986883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An integrated approach to the prediction of chemotherapeutic response in patients with breast cancer.
    Salter KH; Acharya CR; Walters KS; Redman R; Anguiano A; Garman KS; Anders CK; Mukherjee S; Dressman HK; Barry WT; Marcom KP; Olson J; Nevins JR; Potti A
    PLoS One; 2008 Apr; 3(4):e1908. PubMed ID: 18382681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequential adjuvant therapy: the Memorial Sloan-Kettering Cancer Center experience.
    Hudis C; Seidman A; Raptis G; Fennelly D; Gilewski T; Baselga J; Theodoulou M; Sklarin N; Moynahan M; Surbone A; Currie V; Lebwohl D; Uhlenhopp M; Crown J; Norton L
    Semin Oncol; 1996 Feb; 23(1 Suppl 1):58-64. PubMed ID: 8629040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells.
    Foroodi F; Duivenvoorden WC; Singh G
    Anticancer Drugs; 2009 Feb; 20(2):115-22. PubMed ID: 19209028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fractionated irradiation induced radio-resistant esophageal cancer EC109 cells seem to be more sensitive to chemotherapeutic drugs.
    Xie L; Song X; Yu J; Wei L; Song B; Wang X; Lv L
    J Exp Clin Cancer Res; 2009 May; 28(1):68. PubMed ID: 19470182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic cyclophosphamide treatment alters the expression of stress response genes in rat male germ cells.
    Aguilar-Mahecha A; Hales BF; Robaire B
    Biol Reprod; 2002 Apr; 66(4):1024-32. PubMed ID: 11906922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melatonin potentiates chemotherapy-induced cytotoxicity and apoptosis in rat pancreatic tumor cells.
    Uguz AC; Cig B; Espino J; Bejarano I; Naziroglu M; Rodríguez AB; Pariente JA
    J Pineal Res; 2012 Aug; 53(1):91-8. PubMed ID: 22288984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination treatment with fulvestrant and various cytotoxic agents (doxorubicin, paclitaxel, docetaxel, vinorelbine, and 5-fluorouracil) has a synergistic effect in estrogen receptor-positive breast cancer.
    Ikeda H; Taira N; Nogami T; Shien K; Okada M; Shien T; Doihara H; Miyoshi S
    Cancer Sci; 2011 Nov; 102(11):2038-42. PubMed ID: 21801281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential mechanisms for chemotherapy-induced impairments in cognitive function.
    Jansen C; Miaskowski C; Dodd M; Dowling G; Kramer J
    Oncol Nurs Forum; 2005 Nov; 32(6):1151-63. PubMed ID: 16270111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DL-Methadone as an Enhancer of Chemotherapeutic Drugs in Head and Neck Cancer Cell Lines.
    Landgraf V; Griessmann M; Roller J; Polednik C; Schmidt M
    Anticancer Res; 2019 Jul; 39(7):3633-3639. PubMed ID: 31262889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spermiogenic germ cell phase-specific DNA damage following cyclophosphamide exposure.
    Codrington AM; Hales BF; Robaire B
    J Androl; 2004; 25(3):354-62. PubMed ID: 15064312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical study of comparison of CAF regimen and TP regimen in treatment of advanced breast cancer].
    Lin XG; Xie DR; Yao HR; Li ZH; Jiang ZM; Liu TH
    Ai Zheng; 2003 Apr; 22(4):411-4. PubMed ID: 12704001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.